Hardy Reed
ABBV icon

Hardy Reed’s AbbVie ABBV Stock Holding History

Hardy Reed’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.58M Buy
9,849
+233
+2% +$59.7K 0.16% 59
2026
Q2 		$2.42M Sell
9,616
-296
-3% -$63.7K 0.16% 61
2026
Q1 		$2.16M Sell
9,912
-475
-5% -$105K 0.16% 59
2025
Q4 		$2.37M Buy
10,387
+126
+1% +$28.7K 0.17% 55
2025
Q3 		$2.38M Buy
10,261
+415
+4% +$84.5K 0.17% 50
2025
Q2 		$1.83M Sell
9,846
-1,802
-15% -$335K 0.15% 67
2025
Q1 		$2.44M Buy
11,648
+134
+1% +$26K 0.22% 46
2024
Q4 		$2.05M Sell
11,514
-16
-0.1% -$2.94K 0.18% 54
2024
Q3 		$2.28M Buy
11,530
+3
+0% +$560 0.2% 51
2024
Q2 		$1.98M Buy
+11,527
New +$1.91M 0.2% 50

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Hardy Reed's ABBV Position: Q3 2026 in Review

Hardy Reed increased its AbbVie (ABBV) stake by 2.4% in Q3 2026, buying an estimated $59.7K and bringing the position to 9,849 shares worth $2.58M. The position accounts for 0.16% of the portfolio, ranked #59.

Hardy Reed first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 2,727 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Hardy Reed held 9,849 shares of AbbVie worth $2.58M as of Q3 2026.
  • Hardy Reed bought 233 AbbVie shares in Q3 2026, an estimated $59.7K.
  • AbbVie made up 0.16% of Hardy Reed's portfolio in Q3 2026, its #59 holding.
  • Hardy Reed first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
  • 2,727 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.